微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.96% | -36.89% | 21.81% | 33/68 | 2.72% | 羚锐制药 | 13.11% | 行业排名> |
| 2026-03-31 | 2.43% | 16.27% | -65.68% | 34/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 7.08% | 212.38% | 12.38% | 26/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 6.3% | 84.75% | 34.33% | 28/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 4.69% | 18.14% | 124.4% | 25/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 2.09% | 78.63% | 133.17% | 36/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | -6.3% | -182.68% | -284.75% | 57/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 3.41% | -52.04% | -14.11% | 40/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 3.97% | -35.24% | 239.32% | 31/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 1.17% | -68.63% | -84.65% | 46/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 7.62% | -9.07% | 7.17% | 30/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.11% | 1.86% | 15.99% | 35/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 6.13% | 16.54% | 64.34% | 20/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.73% | 75.94% | -55.49% | 23/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 8.38% | 3.2% | 20.06% | 30/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 6.98% | -17.4% | 32.7% | 34/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 5.26% | -5.73% | 148.11% | 23/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.12% | 34.18% | -73.89% | 37/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 8.12% | 148.62% | -3.91% | 30/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 8.45% | 16.23% | 51.43% | 29/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 5.58% | 95.79% | 253.16% | 25/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 1.58% | 22.48% | 109.46% | 47/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | -16.7% | -325.37% | -329.71% | 63/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 7.27% | -20.55% | 155.09% | 32/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 2.85% | -61.17% | 120.93% | 42/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 1.29% | -59.05% | -82.59% | 47/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 7.41% | -32.02% | -19.02% | 36/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 9.15% | -0.33% | 24.66% | 19/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 7.34% | 5.01% | 133.02% | 15/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 3.15% | -3.08% | -71.1% | 24/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 10.9% | 16.95% | 18.74% | 28/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 9.18% | 1.77% | 31.33% | 24/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 6.99% | 1.75% | 115.08% | 21/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 3.25% | 1.25% | -65.13% | 24/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 9.32% | -35.1% | 3.33% | 38/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 9.02% | -31.82% | 31.3% | 25/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 6.87% | -32.38% | 114.02% | 22/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 3.21% | -26.88% | -77.65% | 23/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 14.36% | -2.58% | 8.54% | 18/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 13.23% | 16.15% | 30.22% | 9/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 10.16% | 31.44% | 131.44% | 6/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 4.39% | 27.99% | -70.22% | 12/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |